Medeuronet acquires IROC Science’s clinical studies business

Switzerland-based IROC Science’s clinical study business assets have been acquired by the medical device consulting firm Medeuronet, according to a press release.

The private transaction will allow IROC Science to continue to operate in collaboration with Medeuronet, focusing on developing ophthalmology products for market entry in Europe, the release said.

“After collaborating on ophthalmology projects over the past 5 years, this acquisition of IROC Science’s clinical business makes sense given Medeuronet’s growing focus on clinical study services in ophthalmology,” said Kristine Morrill, Medeuronet co-founder and lead on clinical studies and medical communications services.

 

Switzerland-based IROC Science’s clinical study business assets have been acquired by the medical device consulting firm Medeuronet, according to a press release.

The private transaction will allow IROC Science to continue to operate in collaboration with Medeuronet, focusing on developing ophthalmology products for market entry in Europe, the release said.

“After collaborating on ophthalmology projects over the past 5 years, this acquisition of IROC Science’s clinical business makes sense given Medeuronet’s growing focus on clinical study services in ophthalmology,” said Kristine Morrill, Medeuronet co-founder and lead on clinical studies and medical communications services.